Unlocking ferroptosis heterogeneity: ATF4 versus SREBF transcriptional programs

Area of Science:

• Cellular Biology
• Biochemistry
• Molecular Biology

Background:

• Regulated cell death (RCD) includes diverse forms like ferroptosis, an iron-dependent process marked by lipid peroxide accumulation.
• Ferroptosis exhibits heterogeneous regulation, suggesting multiple underlying pathways and potential overlap with other cell death forms.
• Understanding ferroptosis mechanisms is crucial due to its implications in various physiological and pathological conditions.

Purpose of the Study:

• To investigate the distinct regulatory pathways governing ferroptosis induction and function.
• To elucidate the roles of GPX4 and the Xc⁻/GSH system in ferroptosis.
• To identify key molecular players and signaling cascades involved in ferroptosis.

Main Methods:

• Utilized genetic GPX4 knockout and chemical inhibition (ML210) to study ferroptosis.
• Investigated the Xc⁻/GSH system's role through its inhibition.
• Analyzed changes in mevalonate pathway regulators (SREBF1, SREBF2) and ATF4 under different conditions.

Main Results:

• GPX4 inhibition upregulated mevalonate pathway regulators (SREBF1/2), indicating compensatory anti-ferroptotic mechanisms.
• Xc⁻/GSH system inhibition led to ferroptosis and downregulated SREBF cascades.
• ATF4 was identified as a key regulator for cystine uptake and glutathione biosynthesis in the Xc⁻/GSH pathway.

Conclusions:

• Ferroptosis is a heterogeneous cell death spectrum with multiple interacting, mechanistically distinct pathways.
• The GPX4 and Xc⁻/GSH/ATF4 pathways represent key, yet separate, regulatory mechanisms in ferroptosis.
• This research provides a valuable multi-omics resource for advancing ferroptosis studies.